Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will hold a conference call on November 11, 2011 to discuss the financial results for the third quarter ended September 30, 2011. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
DSCI to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15, 2011 at 3:00 p.m. ET. The conference is being held September 15-16, 2011 at the Pierre Hotel in New York City. Edward J. Quilty, Chairman and CEO, will deliver the Company's corporate presentation.